日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase II Study of (177)Lu-Lilotomab Satetraxetan, a CD37 Antibody-Radionuclide Conjugate, as Third- or Later-Line Treatment of Rituximab-Refractory Follicular B-Cell Lymphoma Patients

一项 II 期研究评估 (177)Lu-Lilotomab Satetraxetan(一种 CD37 抗体-放射性核素偶联物)作为利妥昔单抗难治性滤泡性 B 细胞淋巴瘤患者的三线或后续治疗方案的疗效

Larsen, Roy H; Kolstad, Arne; Fosså, Alexander; Repetto-Llamazares, Ada; Smerud, Knut T; Illidge, Timothy; Bruland, Øyvind S

CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia

靶向CD371并分泌白细胞介素-18的CAR-T细胞表现出强大的扩增能力,并能清除难治性急性髓系白血病。

Geyer, Mark B; DeWolf, Susan; Mi, Xiaoli; Weis, Kenyon; Shaffer, Brian C; Cadzin, Briana; McAvoy, Devin; Katsamakis, Zoe; Lorenc, Rachel; Lewis, Alexander M; Gipson, Brianna; Cuibus, M Adriana; Girotra, Narina N; Wu, Kenton; Smith, Natalie; Burns, Erin R; Um, Jasmine S; Yoo, Sarah; Masouleh, Behzad Kharabi; Galera, Pallavi; Hosszu, Kinga; Chaudhari, Jagrutiben; Wang, Xiuyan; Lin, Qianqian; Curran, Kevin J; Park, Jae H; Scheinberg, David A; van den Brink, Marcel R M; Abdel-Wahab, Omar; Brentjens, Renier J; Daniyan, Anthony F

Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma

将MCL-1抑制剂与CD37靶向嵌合抗原受体T细胞相结合,是治疗T细胞淋巴瘤的有效策略。

Heavican-Foral, Tayla B; Korell, Felix; Scarfò, Irene; Wiggers, Caroline R M; B, Allen Thayakumar; Eisenbies, Zachary; Powers, Foster; Hegel, Justin; Liu, Jianlin; Kulp, Steffen; Silva, Harrison; Wu, Gongwei; Letai, Anthony; Stegmaier, Kimberly; Lohr, Jens G; Weinstock, David M; Maus, Marcela V; Knoechel, Birgit

CD37 regulates the self-renewal of leukemic stem cells via integrin-mediated signaling in acute myeloid leukemia

CD37通过整合素介导的信号通路调节急性髓系白血病中白血病干细胞的自我更新

Lu, Jinyuan; Lv, Lixin; Tian, Xiaoxue; Li, Zheng; Ma, Yuting; Li, Nannan; Wang, Jian; Wang, Guangming; Zeng, Yu; Zhang, Wenjun; Xu, Jun; Liang, Aibin

Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies

CAR-37 T 细胞治疗复发或难治性 CD37+ 淋巴瘤患者的 I 期研究

Frigault, Matthew J; Graham, Charlotte E; Berger, Trisha R; Ritchey, Julie; Horick, Nora K; El-Jawahri, Areej; Scarfò, Irene; Schmidts, Andrea; Haradhvala, Nicholas J; Wehrli, Marc; Lee, Won-Ho; Parker, Aiyana L; Wiggin, Hadley R; Bouffard, Amanda; Dey, Aonkon; Leick, Mark B; Katsis, Katelin; Elder, Eva L; Dolaher, Maria A; Cook, Daniella T; Chekmasova, Alena A; Huang, Lu; Nikiforow, Sarah; Daley, Heather; Ritz, Jerome; Armant, Myriam; Preffer, Fred; DiPersio, John F; Nardi, Valentina; Chen, Yi-Bin; Gallagher, Kathleen M E; Maus, Marcela V

CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia

CD37 是一种安全的嵌合抗原受体靶点,可用于治疗急性髓系白血病。

Benjamin Caulier,Sandy Joaquina,Pascal Gelebart,Tara Helén Dowling,Fatemeh Kaveh,Moritz Thomas,Luka Tandaric,Patrik Wernhoff,Niveditha Umesh Katyayini,Cara Wogsland,May Eriksen Gjerstad,Yngvar Fløisand,Gunnar Kvalheim,Carsten Marr,Sebastian Kobold,Jorrit M Enserink,Bjørn Tore Gjertsen,Emmet McCormack,Else Marit Inderberg,Sébastien Wälchli

PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas

PI3Kδ激活、IL-6过表达和CD37缺失导致淋巴瘤对那拉妥昔单抗-美坦新产生耐药性

Arribas, Alberto J; Napoli, Sara; Gaudio, Eugenio; Herbaux, Charles; Cannas, Eleonora; Tarantelli, Chiara; Bordone-Pittau, Roberta; Cascione, Luciano; Munz, Nicolas; Aresu, Luca; Sgrignani, Jacopo; Rinaldi, Andrea; Kwee, Ivo; Rossi, Davide; Cavalli, Andrea; Zucca, Emanuele; Stussi, Georg; Stathis, Anastasios; Sloss, Callum; Davids, Matthew S; Bertoni, Francesco

Diagnostic value of sphingolipid metabolism-related genes CD37 and CXCL9 in nonalcoholic fatty liver disease

鞘脂代谢相关基因CD37和CXCL9在非酒精性脂肪性肝病诊断中的价值

Zhang, Jiayi; Wang, Lingfang; Jiang, Meixiu

Protocol for the development of a bioluminescent AML-PDX mouse model for the evaluation of CAR T cell therapy

用于评估 CAR-T 细胞疗法的生物发光 AML-PDX 小鼠模型的开发方案

Mireia Mayoral Safont, Calum Leitch, Mihaela Popa, May Eriksen Gjerstad, Benjamin Caulier, Else Marit Inderberg, Sébastien Wälchli, Pascal Gelebart, Emmet Mc Cormack

Flow cytometric signature of CD371-positive B-cell acute lymphoblastic leukemia

CD371阳性B细胞急性淋巴细胞白血病的流式细胞术特征

Shakah, Hind; Tbakhi, Abdelghani; Khudirat, Saleh; Abweh, Ruba Al; Hasasna, Nabil; Alwhaidi, Alaa; Khoujah, Abdallah; Barakat, Fareed